These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 20452679)
21. Fn14-Fc fusion protein regulates atherosclerosis in ApoE-/- mice and inhibits macrophage lipid uptake in vitro. Schapira K; Burkly LC; Zheng TS; Wu P; Groeneweg M; Rousch M; Kockx MM; Daemen MJ; Heeneman S Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2021-7. PubMed ID: 19762780 [TBL] [Abstract][Full Text] [Related]
22. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia. Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases. Yepes M; Winkles JA Drug News Perspect; 2006 Dec; 19(10):589-95. PubMed ID: 17299600 [TBL] [Abstract][Full Text] [Related]
24. TWEAK is a positive regulator of cardiomyocyte proliferation. Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380 [TBL] [Abstract][Full Text] [Related]
26. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561 [TBL] [Abstract][Full Text] [Related]
27. Proinflammatory effect of TWEAK/Fn14 interaction in human retinal pigment epithelial cells. Ebihara N; Nakayama M; Tokura T; Iwatsu M; Ushio H; Murakami A Curr Eye Res; 2009 Oct; 34(10):836-44. PubMed ID: 19895311 [TBL] [Abstract][Full Text] [Related]
28. TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage. Kaduka Y; Takeda K; Nakayama M; Kinoshita K; Yagita H; Okumura K Biochem Biophys Res Commun; 2005 Jun; 331(2):384-90. PubMed ID: 15850771 [TBL] [Abstract][Full Text] [Related]
29. Role of the TWEAK/Fn14 pathway in autoimmune diseases. Xu WD; Zhao Y; Liu Y Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091 [TBL] [Abstract][Full Text] [Related]
30. Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity. Chacón MR; Richart C; Gómez JM; Megía A; Vilarrasa N; Fernández-Real JM; García-España A; Miranda M; Masdevall C; Ricard W; Caubet E; Soler J; Vendrell J Cytokine; 2006 Feb; 33(3):129-37. PubMed ID: 16503147 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway. Michaelson JS; Burkly LC Results Probl Cell Differ; 2009; 49():145-60. PubMed ID: 19513634 [TBL] [Abstract][Full Text] [Related]
32. TWEAK/Fn14 signaling in tumors. Hu G; Zeng W; Xia Y Tumour Biol; 2017 Jun; 39(6):1010428317714624. PubMed ID: 28639899 [TBL] [Abstract][Full Text] [Related]
33. Role of TWEAK and Fn14 in tumor biology. Winkles JA; Tran NL; Brown SA; Stains N; Cunliffe HE; Berens ME Front Biosci; 2007 Jan; 12():2761-71. PubMed ID: 17127278 [TBL] [Abstract][Full Text] [Related]
34. Considering TWEAK as a target for therapy in renal and vascular injury. Ortiz A; Sanz AB; Muñoz García B; Moreno JA; Sánchez Niño MD; Martín-Ventura JL; Egido J; Blanco-Colio LM Cytokine Growth Factor Rev; 2009 Jun; 20(3):251-8. PubMed ID: 19482507 [TBL] [Abstract][Full Text] [Related]